• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

GenMark Diagnostics Inc

+ Add to Watchlist


7.886 EUR 0.214 2.64%

As of 09:34:00 ET on 07/30/2014.

Snapshot for GenMark Diagnostics Inc (GNF)

Open: 7.886 Day's Range: 7.886 - 7.886 Volume: 0
Previous Close: 8.100 52wk Range: 6.190 - 10.163 1-Yr Rtn: +8.88%

Stock Chart for GNF

No chart data available.
  • GNF:GR 7.886
  • 1D
  • 1M
  • 1Y
Interactive GNF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GNF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.1530
Est. PEG Ratio -
Market Cap (M EUR) 328.14
Shares Outstanding (M) 41.61
30 Day Average Volume 25
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/11/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GNF

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GNF

GenMark Diagnostics Inc. is a molecular diagnostics company focused on developing and commercializing its biomarker detection technology. The Company's system supports a broad range of molecular diagnostic tests with a compact workstation and self-contained, disposable test cartridges.

Hany MassaranyPresident/CEOScott MendelChief Financial Officer
Eric StierSenior VP/General Counsel/SecyJon Faiz KayyemSenior VP:R&D/Chief Scientific Ofcr
More Company Profile & Key Executives for GNF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil